| Literature DB >> 35508687 |
Xutao Xi1, Arshad Mehmood2, Pengyan Niu3, Jinjie Yang3, Yintian Wang3, Heyu Zhou3, Xiaohui Han3, Lifen Ma4, Shiying Jin4, Yinxia Wu4.
Abstract
Knee osteoarthritis (OA) is the most prevalent type of OA, and Toll-like receptor 7 (TLR7) may lead to the pathogenesis of OA. Recently, X-linked TLR7 polymorphism has been confirmed to be associated with arthritis. However, there is a lack of studies on TLR7 gene polymorphism associated with knee OA susceptibility. The current study aimed to determine whether TLR7 gene polymorphism is associated with the risk of knee OA. Genotyping of two polymorphic sites (rs3853839 and rs179010) in the TLR7 gene was performed in 252 OA patients, and 265 healthy controls using the SNaPshot sequencing technique. Data were analyzed statistically by Chi-square tests and logistic regression. Rs3853839-C allele showed frequencies of 28% and 27% in the healthy control and female knee OA groups, respectively. The differences were not statistically significant (P > 0.05). The rs3853839-CG genotype frequency was significantly lower in the female knee OA group as compared to the healthy control group (OR 0.60; 95%CI 0.36-0.99; P = 0.044). In the male hemizygote population, the rs3853839-CC showed significantly lower frequencies in the male knee OA group as compared to the healthy control group (OR 0.35; 95%CI 0.17-0.71; P = 0.0025). Regarding rs179010, there were no differences in the genotype distribution and allele frequencies between OA patients and healthy subjects under any models (P > 0.05). Stratified analysis showed that the frequency of the rs3853839-CG genotypes was lower in high Kellgren-Lawrence grades (KLG) (OR 0.48; 95%CI 0.21-1.08; P = 0.066), and significantly lower in OA patients with effusion synovitis (OR 0.38; 95%CI 0.17-0.88; P = 0.013). TLR7 rs3853839 polymorphism may play a role in the susceptibility of knee OA in the Chinese Han Population and may be associated with OA severity and the risk of effusion synovitis in Knee OA.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35508687 PMCID: PMC9068723 DOI: 10.1038/s41598-022-11296-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Primer information and primer sequences of TLR7.
| Genes | Upstream primer | Downstream primer | Extension primer |
|---|---|---|---|
| rs3853839 | CCATTCTGTGC | CTTTCTTTCTTACT | CTGACTGGGAACCC |
| AGATTGAG | GTTTCCCTA | AGAAGCAGGCCCAAG | |
| rs179010 | AGTTATACGGTT | CCTACACATTGGG | TCCTCTGATTATGTA |
| CCTCTGATTA | TTTACATT | TCACC |
Demographics and clinical characteristics of participants for TLR7 SNP.
| Clinical characteristics | Knee OA | HC | |
|---|---|---|---|
| n = 252 | n = 266 | ||
| Sex | 0.4916 | ||
| Females | 146 | 158 | |
| Males | 106 | 108 | |
| Age, y (mean ± SD) | 56 ± 15 | 55 ± 11 | 0.372 |
| Smoking | 0.075 | ||
| Yes | 71 | 57 | |
| No | 118 | 209 | |
| Drinking | 0.392 | ||
| Yes | 57 | 52 | |
| No | 195 | 214 | |
| Body mass index (kg/m2) | 24.3 ± 2.21 | 24.0 ± 1.92 | 0.088 |
| Kellgren–Lawrence grade | |||
| 2 | 63 | NA | NA |
| 3 | 97 | NA | NA |
| 4 | 92 | NA | NA |
| MRI of knee WORMS score | |||
| 0 | 32 | NA | NA |
| 1 | 23 | NA | NA |
| 2 | 45 | NA | NA |
| 3 | 25 | NA | NA |
Knee OA knee osteoarthritis patients group, HC healthy control group, SD standard deviation, NA not assessable, WORMS Semiquantitative whole-organ MRI scoring.
Selected SNPs of TLR7 and PHWE in this study.
| SNPs | Location | Group | Genotype (n) | PHWE | 1000genome CHBs | Nucleotide | Functional region | ||
|---|---|---|---|---|---|---|---|---|---|
| rs3853839 | X:12889539 | CC | CG | GG | G = 0.40 | ||||
| (GRCh38) | Knee OA (n = 146) | 87 | 40 | 19 | C > G | 3_prime_UTR | |||
| HC (n = 158) | 82 | 60 | 16 | ||||||
| rs179010 | X:12884766 | CC | CT | TT | T = 0.29 | ||||
| (GRCh38) | Knee OA (n = 146) | 78 | 50 | 18 | 0.045 | T > C | Intron | ||
| HC (n = 158) | 78 | 59 | 21 | 0.098 | |||||
Knee OA osteoarthritis patients group, HC healthy control group, PHWE P value of Hardy–Weinberg equilibrium.
Association analysis between SNPs and the female Knee OA risk under different models.
| SNPs | Model | Genotype | HC (n = 158) | Knee OA (n = 146) | OR (95% CI) | |
|---|---|---|---|---|---|---|
| rs3853839 | Allele | G | 224 (72%) | 214 (73%) | 1 | 0.50 |
| C | 92 (28%) | 78 (27%) | 0.88 (0.62–1.26) | |||
| Codominant | G/G | 82 (51.9%) | 87 (59.6%) | 1 | 0.13 | |
| C/G | 60 (38%) | 40 (27.4%) | 0.59 (0.35–0.99) | |||
| C/C | 16 (10.1%) | 19 (13%) | 0.90 (0.39–2.07) | |||
| Dominant | G/G | 82 (51.9%) | 87 (59.6%) | 1 | 0.072 | |
| C/G-C/C | 76 (48.1%) | 59 (40.4%) | 0.65 (0.40–1.04) | |||
| Recessive | G/G-C/G | 142 (89.9%) | 127 (87%) | 1 | 0.84 | |
| C/C | 16 (10.1%) | 19 (13%) | 1.09 (0.48–2.45) | |||
| Overdominant | G/G-C/C | 98 (62%) | 106 (72.6%) | 1 | 0.044 | |
| C/G | 60 (38%) | 40 (27.4%) | 0.60 (0.36–0.99) | |||
| rs179010 | Allele | C | 215(0.68) | 206(0.71) | 1 | 0.50 |
| T | 101(0.32) | 86(0.29) | 1.12(0.79–1.58) | |||
| Codominant | C/C | 78 (49.4%) | 78 (53.4%) | 1 | 0.93 | |
| C/T | 59 (37.3%) | 50 (34.2%) | 0.97 (0.57–1.63) | |||
| T/T | 21 (13.3%) | 18 (12.3%) | 0.86 (0.42–1.80) | |||
| Dominant | C/C | 78 (49.4%) | 78 (53.4%) | 1 | 0.79 | |
| C/T-T/T | 80 (50.6%) | 68 (46.6%) | 0.94 (0.58–1.52) | |||
| Recessive | C/C–C/T | 137 (86.7%) | 128 (87.7%) | 1 | 0.71 | |
| T/T | 21 (13.3%) | 18 (12.3%) | 0.88 (0.44–1.76) | |||
| Overdominant | C/C-T/T | 99 (62.7%) | 96 (65.8%) | 1 | 0.99 | |
| C/T | 59 (37.3%) | 50 (34.2%) | 1.00 (0.60–1.64) |
Knee OA osteoarthritis patients group, HC healthy control group, OR odds ratios, CI confidence intervals. The data adjusted by smoke + drinking + age + BMI.
Association analysis between SNPs and the male Knee OA risk.
| SNPs | Genotype | HC (n = 108) | Knee OA (n = 106) | OR (95% CI) | |
|---|---|---|---|---|---|
| rs3853839 | G/G | 75 (69.4%) | 84 (79.2%) | 1 | 0.0029 |
| C/C | 33 (30.6%) | 22 (20.8%) | 0.35 (0.17–0.71) | ||
| rs179010 | C/C | 96 (88.9%) | 95 (89.6%) | 1 | 0.7 |
| T/T | 12 (11.1%) | 11 (10.4%) | 1.21 (0.47–3.11) |
Knee OA osteoarthritis patients group, HC healthy control group, OR odds ratios, CI confidence intervals; The data adjusted by smoke + drinking + age + BMI.
Figure 1Linkage disequilibrium (LD) patterns in TLR7. D' (A) and r2 (B) mean LD coefficients of the two SNPs. Each block represents the LD relationship between two SNPs. Rs3853839 indicated no LD with rs179010.
Stratified analyses based on clinical features for the association between TLR7 polymorphism and the risk of Knee OA.
| SNPs | Genotype | Clinical features items | OR (95% CI) | ||
|---|---|---|---|---|---|
| rs3853839 | G/G-C/C | 44 (77.2%) | 62 (69.7%) | 1 | 0.99 |
| C/G | 13 (22.8%) | 27 (30.3%) | 0.99 (0.34–2.89) | ||
| rs179010 | C/C-T/T | 39 (68.4%) | 57 (64%) | 1 | 0.2 |
| C/T | 18 (31.6%) | 32 (36%) | 0.51 (0.18–1.44) | ||
| rs3853839 | G/G-C/C | 47 (69.1%) | 59 (75.6%) | 1 | 0.38 |
| C/G | 21 (30.9%) | 19 (24.4%) | 0.72 (0.34–1.51) | ||
| rs179010 | G/G-C/C | 47 (69.1%) | 59 (75.6%) | 1 | 0.38 |
| C/G | 21 (30.9%) | 19 (24.4%) | 0.72 (0.34–1.51) | ||
| rs3853839 | G/G-C/C | 130 (81.2%) | 82 (89.1%) | 1 | 0.066 |
| C/G | 30 (18.8%) | 10 (10.9%) | 0.48 (0.21–1.08) | ||
| rs179010 | C/C-T/T | 125 (78.1%) | 77 (83.7%) | 1 | 0.2 |
| C/T | 35 (21.9%) | 15 (16.3%) | 0.63 (0.31–1.29) | ||
| rs3853839 | G/G-C/C | 135 (79.4%) | 77 (93.9%) | 1 | 0.53 |
| C/G | 35 (20.6%) | 5 (6.1%) | 0.71 (0.24–2.08) | ||
| rs179010 | C/C-T/T | 128 (75.3%) | 74 (90.2%) | 1 | 0.91 |
| C/T | 42 (24.7%) | 8 (9.8%) | 0.95 (0.37–2.40) | ||
Knee OA osteoarthritis patients group, HC healthy control group, OR Odds ratios, CI confidence intervals, KLG Kellgren-Lawrence grade, BMI Body Mass Index. The data adjusted by moke + drinking + age + BMI.
Association between TLR7 polymorphism and the risk of effusion with synovitis in Knee OA.
| SNPs | Model | Genotype | HC | Effusion synovitis | OR (95% CI) | |
|---|---|---|---|---|---|---|
| rs3853839 | Codominant | G/G | 157 (59%) | 64 (71.9%) | 1 | 0.054 |
| C/G | 60 (22.6%) | 11 (12.4%) | 0.45 (0.22–0.91) | |||
| C/C | 49 (18.4%) | 14 (15.7%) | 0.70 (0.36–1.36) | |||
| Dominant | G/G | 157 (59%) | 64 (71.9%) | 1 | 0.028 | |
| C/G-C/C | 109 (41%) | 25 (28.1%) | 0.56 (0.33–0.95) | |||
| Recessive | G/G-C/G | 217 (81.6%) | 75 (84.3%) | 1 | 0.56 | |
| C/C | 49 (18.4%) | 14 (15.7%) | 0.83 (0.43–1.58) | |||
| Overdominant | G/G-C/C | 206 (77.4%) | 78 (87.6%) | 1 | 0.03 | |
| C/G | 60 (22.6%) | 11 (12.4%) | 0.48 (0.24–0.97) | |||
| rs179010 | Codominant | C/C | 174 (65.4%) | 63 (70.8%) | 1 | 0.57 |
| C/T | 59 (22.2%) | 18 (20.2%) | 0.84 (0.46–1.54) | |||
| T/T | 33 (12.4%) | 8 (9%) | 0.67 (0.29–1.53) | |||
| Dominant | C/C | 174 (65.4%) | 63 (70.8%) | 1 | 0.35 | |
| C/T-T/T | 92 (34.6%) | 26 (29.2%) | 0.78 (0.46–1.32) | |||
| Recessive | C/C–C/T | 233 (87.6%) | 81 (91%) | 1 | 0.37 | |
| T/T | 33 (12.4%) | 8 (9%) | 0.70 (0.31–1.57) | |||
| Overdominant | C/C-T/T | 207 (77.8%) | 71 (79.8%) | 1 | 0.7 | |
| C/T | 59 (22.2%) | 18 (20.2%) | 0.89 (0.49–1.61) |
Knee OA osteoarthritis patients group, HC healthy control group, OR Odds ratios, CI confidence intervals; The data adjusted by smoke + drinking + age + BMI.